£9.54 Exc. VAT
P U R E • M I X & M A T C H • V E G A N
+ Pure Formula
Here at Epigenetics, the quality and purity of each ingredient is integral to our development of effective, bioavailable formulas. Our products are naturally pesticide-free and completely free from artificial fillers, additives, lubricants, binders, bulking agents and preservatives.
+ Clinically Researched
Our formulations are carefully constructed using a combined 70+ years of clinical research and experience in treating patients, conducted by our very own resident health care practitioners.
+ Designed for Mixing
Create your own bespoke probiotic mix without needing to take lots of capsules daily. Combine with other Epigenetics probiotic powders or take alone. Each sachet provides 15g (15 servings); combine to increase your supply whilst continuing to take 1g a day.
+ Vegan Friendly
We respect nature and as such we do our part and only use vegan-friendly ingredients in our Bifidobacterium Longum.
+ Letterbox Friendly
Our powders come in small sachets, designed for easy, contact-free delivery. The smaller design leads to a reduced carbon footprint during the shipping process.
Please be aware that due to the nature of our probiotic products, we will not be able to receive this item back should you wish to return it. For this reason it’s advised that you take care when ordering, as we may not be able to offer you a refund.
In stock
Please be aware that on recipt of the product, it must be stored in the refrigerator. Add a pot & scoop to your order to better store your probiotics and make dosing and mixing powders easier.
https://epigenetics-international.com/product/100ml-pot-scoop/
https://epigenetics-international.com/product/250ml-pot-scoop/
| Ingredient | Amount per serving | ECRDA* | %DV* |
| Inulin (from Jerusalem artichoke) | 855 mg | † | † |
| Bifidobacterium longum | 50 mg (5B CFU) | † | † |
† Percent Daily Reference Intakes (RI) not established.
INGREDIENTS: Organic Jerusalem artichoke tuber extract (Helianthus tuberosus), Bifidobacterium longum.
Suitable for vegans
One of the most well-established benefits of Bifidobacterium longum is its ability to modulate the immune system. According to research, Bifidobacterium longum exhibits potential effects on the immune system by reinforcing the body’s defences against detrimental pathogens. In infants, Bifidobacterium longum has been observed to trigger the anti-poliovirus response and heighten their resistance to respiratory tract infections. For the elderly, Bifidobacterium longum is particularly significant as it has been demonstrated to enhance their immune system. Furthermore, in a study involving mice infected with influenza, Bifidobacterium longum was found to ameliorate symptoms, decrease mortality rates, and reduce inflammation in the lower respiratory tract (1).
Bifidobacterium longum may play a role in the gut microbiota. Certain strains of Enterotoxigenic Bacteroides fragilis (ETBF) have been linked to acute and persistent diarrhoea, inflammatory bowel disease, and colorectal cancer. However, Bifidobacterium longum has been shown to significantly decrease ETBF levels in humans. Likewise, In elderly patient receiving enteral feeding, Bifidobacterium longum was observed to modulate the intestinal environment and improve their general health. In mice, Bifidobacterium longum supplementation increased biotin levels produced by Bacteroides caccae and elevated Eubacterium rectale, a butyrate producer. Bifidobacterium longum was also found to maintain high Lactobacilli levels in mice and reduce endotoxins in rats when administered as Bifidobacterium longum ssp. Infantis. Additionally, Bifidobacterium longum ssp. Infantis was seen to increase propionic, succinic, and butyric acid levels in rats, highlighting the probiotics ability to positively modulate the gut microbiota (2).
Bifidobacterium longum ssp. Infantis, has been demonstrated to be effective in reducing intestinal inflammation and treating individual and global symptoms of irritable bowel syndrome (IBS) without any adverse effects. Studies have found that Bifidobacterium longum ssp. Infantis improved abdominal pain/discomfort, bloating/distention, and bowel movement difficulties in IBS patients, and a clinical trial involving women further confirmed the effectiveness of Bifidobacterium longum ssp. Infantis in alleviating multiple symptoms of IBS. In addition to IBS, Bifidobacterium longum has been found to ameliorate symptoms of ulcerative colitis in both Japanese patients and mice, along with Bifidobacterium longum subsp. Infantis. This bacterium has also been shown to reduce visceral hypersensitivity in mice with IBS and significantly decrease the visceral pain threshold pressure of the first pain behaviour and total number of pain behaviours in rats (2).
Overall, Bifidobacterium longum is a promising probiotic strain with a wide range of potential health benefits. While further research is needed to fully understand its mechanisms of action and clinical applications, it is clear that this bacterium plays an important role in promoting overall health and well-being.
Individuals with weakened immune systems may experience blood infections when taking certain probiotics. While this is a rare occurrence, it is important for those with weakened immune systems to consult with their healthcare provider prior to taking any probiotic, including Bifidobacterium longum (3).
Please select this option if your shipping location is located in the UK, Ireland or any other EU or rest of the world country.
UK, Ireland and all other countriesPlease select this option if your shipping location is located only in the United States of America.
USA
